Alterations in mTOR/S6K1 signaling have been observed in AD, influencing key pathological features such as amyloid-β (Aβ) accumulation, tau hyperphosphorylation, and synaptic dysfunction [17,18,19,20,21,22]. The gene discussed is MAPT; the disease is Alzheimer disease.